ABCURO

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both autoimmunity and cancer. They leverage the systematic target validation and clinical insights gained by its founders to identify new targets. Their intensive use of bioinformatics to interrogate the transcriptome of human disease together with ex-vivo validation in diseased tissue has uncovered new approaches to target key compartments of the immune system. The company was incorporated in 2015 and is based in Newton, Massachusetts.

#SimilarOrganizations #People #Financial #Website #More

ABCURO

Social Links:

Linkedin

Industry:

Biotechnology Health Care Medical Therapeutics

Founded:

2015-01-01

Address:

Newton, Massachusetts, United States

Country:

United States

Website Url:

http://www.abcuro.com

Total Employee:

1+

Status:

Active

Contact:

(617) 714-9759‬

Email Addresses:

[email protected]

Total Funding:

59.85 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx Sitelinks Search Box

Similar Organizations

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

slingshot-biosciences-logo

Slingshot Biosciences

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.

Current Advisors List

iyona-rajkomar_image

Iyona Rajkomar Board Member @ Abcuro
Board_member
2021-01-01

not_available_image

Donald McCarthy Board Member @ Abcuro
Board_member
2021-01-01

jason-p-hafler_image

Jason P. Hafler Board Member @ Abcuro
Board_member
2021-01-01

not_available_image

Julius Knowles Board Member @ Abcuro
Board_member
2021-01-01

ryan-berry_image

Ryan Berry Board Member @ Abcuro
Board_member
2021-01-01

not_available_image

Yajun Xu Board Member @ Abcuro
Board_member
2021-01-01

Current Employees Featured

david-de-graaf_image

David de Graaf
David de Graaf President & CEO @ Abcuro
President & CEO
2020-09-01

stefano-gullà_image

Stefano Gullà
Stefano Gullà CEO @ Abcuro
CEO
2016-12-01

darlene-deptula-hicks_image

Darlene Deptula-Hicks
Darlene Deptula-Hicks Board Member & Audit Committee Chair @ Abcuro
Board Member & Audit Committee Chair
2021-07-01

Founder

stefano-gullà_image

Stefano Gullà

Investors List

mass-general-brigham-ventures_image

Mass General Brigham Ventures

Mass General Brigham Ventures investment in Series A - Abcuro

hongsen-investment-group_image

Hongsen Investment Group

Hongsen Investment Group investment in Series A - Abcuro

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series A - Abcuro

samsara-biocapital_image

Samsara BioCapital

Samsara BioCapital investment in Series A - Abcuro

pontifax_image

Pontifax

Pontifax investment in Series A - Abcuro

sanofi-genzyme-bioventures_image

Sanofi Ventures

Sanofi Ventures investment in Series A - Abcuro

kaitai-capital_image

Kaitai Capital

Kaitai Capital investment in Series A - Abcuro

shangpharma-innovation_image

ShangPharma Innovation

ShangPharma Innovation investment in Series A - Abcuro

partners-innovation-fund_image

Partners Innovation Fund

Partners Innovation Fund investment in Series A - Abcuro

Official Site Inspections

http://www.abcuro.com Semrush global rank: 4.75 M Semrush visits lastest month: 1.97 K

Host Informations
Whois Informations

Loading ...

More informations about "Abcuro" on Search Engine